Skip to main content
SpringerLink
Log in

Comparative In Vitro Potency of Gemifloxacin and Fluoroquinolones Against Recent European Clinical Isolates from a Global Surveillance Study

  • Concise Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract.

Gemifloxacin, a new fluoroquinolone with enhanced activity against gram-positive aerobes, was compared to ciprofloxacin, levofloxacin and ofloxacin against 21,464 recent isolates from 16 European countries. Gemifloxacin was the most potent fluoroquinolone against streptococci including penicillin-, macrolide- and ciprofloxacin-resistant Streptococcus pneumoniae, Staphylococcus aureus, coagulase-negative staphylococci, Acinetobacter spp., Haemophilus spp. and Moraxella catarrhalis. This drug was more potent than or comparable to ciprofloxacin against members of the family Enterobacteriaceae, Burkholderia cepacia, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. Gemifloxacin is a promising fluoroquinolone with potent in vitro activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Laboratories International for Microbiology Studies, International Health Management Associates Inc., Rolling Meadows, IL 60008, USA, USA

    D. Hoban, S. Bouchillon, J. Johnson & G. Zhanel

  2. Anti-Infectives Research and Development, SmithKline Beecham Pharmaceuticals, Collegeville, PA, USA, USA

    D. Butler, L. Miller & J. Poupard

Authors
  1. D. Hoban
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Bouchillon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Zhanel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Poupard
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. the Gemifloxacin Surveillance Study Research Group
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoban, D., Bouchillon, S., Johnson, J. et al. Comparative In Vitro Potency of Gemifloxacin and Fluoroquinolones Against Recent European Clinical Isolates from a Global Surveillance Study. Eur J Clin Microbiol Infect Dis 20, 814–819 (2001). https://doi.org/10.1007/s100960100604

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100960100604

Keywords

Search

Navigation